BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16213086)

  • 1. Neuropathic pain associated with non-surgical treatment of breast cancer.
    Jung BF; Herrmann D; Griggs J; Oaklander AL; Dworkin RH
    Pain; 2005 Nov; 118(1-2):10-4. PubMed ID: 16213086
    [No Abstract]   [Full Text] [Related]  

  • 2. A cannabinoid pharmacotherapy for chemotherapy-evoked painful peripheral neuropathy.
    Hohmann AG
    Pain; 2005 Nov; 118(1-2):3-5. PubMed ID: 16203094
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel.
    Reyes-Gibby CC; Morrow PK; Buzdar A; Shete S
    J Pain; 2009 Nov; 10(11):1146-50. PubMed ID: 19595634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in oncology. Case 2. Radiation recall associated with docetaxel.
    Morkas M; Fleming D; Hahl M
    J Clin Oncol; 2002 Feb; 20(3):867-9. PubMed ID: 11821473
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy.
    Azoulay D; Leibovici A; Sharoni R; Shaoul E; Gross B; Braester A; Goldberg H
    Breast Cancer Res Treat; 2015 Oct; 153(3):703-4. PubMed ID: 26272744
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to paclitaxel in a radiotherapy-induced breast angiosarcoma.
    Perez-Ruiz E; Ribelles N; Sanchez-Muñoz A; Roman A; Marquez A
    Acta Oncol; 2009; 48(7):1078-9. PubMed ID: 19235566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paralysis of the peripheral nerve following radiotherapy for mammary carcinoma (author's transl)].
    Asakawa H; Otawa H; Yamada S; Ishii M
    Rinsho Hoshasen; 1980 Apr; 25(4):457-61. PubMed ID: 6247522
    [No Abstract]   [Full Text] [Related]  

  • 10. Invited commentary.
    Campbell KL; McNeely ML
    Phys Ther; 2010 Nov; 90(11):1657-9; author reply 1659. PubMed ID: 21041184
    [No Abstract]   [Full Text] [Related]  

  • 11. Study finds that hormone status may predict chemotherapy's effectiveness on breast cancer.
    McBride D
    ONS Connect; 2008 Jan; 23(1):25. PubMed ID: 18284079
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropathic pain and balance problems are poorly evaluated in patients receiving taxane-based chemotherapy.
    J Support Oncol; 2005; 3(6):412. PubMed ID: 16350427
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropathic pain in cancer.
    Urch CE; Dickenson AH
    Eur J Cancer; 2008 May; 44(8):1091-6. PubMed ID: 18492553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel.
    Golan-Vered Y; Pud D
    Pain Pract; 2013 Jan; 13(1):46-52. PubMed ID: 22533683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves.
    Dellon AL; Swier P; Maloney CT; Livengood MS; Werter S
    Plast Reconstr Surg; 2004 Aug; 114(2):478-83. PubMed ID: 15277817
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
    Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
    Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart health after breast cancer.
    Johns Hopkins Med Lett Health After 50; 2009 Dec; 21(10):1-2. PubMed ID: 20020542
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between paclitaxel and necrotic pancreatitis.
    McMahon MA; Kearns G; McCaffrey J; Grogan L
    Ir Med J; 2006 Oct; 99(9):281. PubMed ID: 17144240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients].
    Inoue K; Ohkubo F; Nagai S; Tsuboi M; Kubo K; Kurozumi K; Hayashi Y; Matsumoto H; Takei H
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1021-5. PubMed ID: 23986044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.